Brain fatty acid synthase activates PPARα to maintain energy homeostasis

Central nervous system control of energy balance affects susceptibility to obesity and diabetes, but how fatty acids, malonyl-CoA, and other metabolites act at this site to alter metabolism is poorly understood. Pharmacological inhibition of fatty acid synthase (FAS), rate limiting for de novo lipogenesis, decreases appetite independently of leptin but also promotes weight loss through activities unrelated to FAS inhibition. Here we report that the conditional genetic inactivation of FAS in pancreatic β cells and hypothalamus produced lean, hypophagic mice with increased physical activity and impaired hypothalamic PPARα signaling. Administration of a PPARα agonist into the hypothalamus increased PPARα target genes and normalized food intake. Inactivation of β cell FAS enzyme activity had no effect on islet function in culture or in vivo. These results suggest a critical role for brain FAS in the regulation of not only feeding, but also physical activity, effects that appear to be mediated through the provision of ligands generated by FAS to PPARα. Thus, 2 diametrically opposed proteins, FAS (induced by feeding) and PPARα (induced by starvation), unexpectedly form an integrative sensory module in the central nervous system to orchestrate energy balance.

[1]  J. Manson,et al.  Body mass index and mortality in men: evaluating the shape of the association , 2007, International Journal of Obesity.

[2]  P. Puigserver,et al.  Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: Role of PGC-1α , 2006, Proceedings of the National Academy of Sciences.

[3]  M. W. Schwartz,et al.  Central nervous system control of food intake and body weight , 2006, Nature.

[4]  T. Harris,et al.  Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.

[5]  C. Lelliott,et al.  Tamoxifen-Induced Anorexia Is Associated With Fatty Acid Synthase Inhibition in the Ventromedial Nucleus of the Hypothalamus and Accumulation of Malonyl-CoA , 2006, Diabetes.

[6]  C. Long,et al.  The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs. , 2006, American journal of physiology. Heart and circulatory physiology.

[7]  A. Pocai,et al.  Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. , 2006, The Journal of clinical investigation.

[8]  Ji-yeon Lee,et al.  RIP-Cre Revisited, Evidence for Impairments of Pancreatic β-Cell Function* , 2006, Journal of Biological Chemistry.

[9]  M. Prentki,et al.  A Role for Hypothalamic Malonyl-CoA in the Control of Food Intake* , 2005, Journal of Biological Chemistry.

[10]  J. Després,et al.  Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. , 2005, The New England journal of medicine.

[11]  M. Lane,et al.  Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Mackie,et al.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. , 2005, The Journal of clinical investigation.

[13]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[14]  Jimmy D Bell,et al.  The role of insulin receptor substrate 2 in hypothalamic and beta cell function. , 2005, The Journal of clinical investigation.

[15]  M. Mcdaniel,et al.  Pancreatic β-Cell Lipoprotein Lipase Independently Regulates Islet Glucose Metabolism and Normal Insulin Secretion* , 2005, Journal of Biological Chemistry.

[16]  Marc Prentki,et al.  Alteration of the malonyl-CoA/carnitine palmitoyltransferase I interaction in the beta-cell impairs glucose-induced insulin secretion. , 2005, Diabetes.

[17]  S. Moreno,et al.  Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS , 2004, Neuroscience.

[18]  Maureen P. Boyle,et al.  Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults , 2004, Neurobiology of Disease.

[19]  Xueying Lin,et al.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. , 2004, The Journal of clinical investigation.

[20]  C. Bogardus,et al.  A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians. , 2004, Diabetes.

[21]  B. Cha,et al.  Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level. , 2004, The Biochemical journal.

[22]  J. Richardson,et al.  Essential Role of STAT3 in Body Weight and Glucose Homeostasis , 2004, Molecular and Cellular Biology.

[23]  S. Woods,et al.  Monitoring of stored and available fuel by the CNS: implications for obesity , 2003, Nature Reviews Neuroscience.

[24]  M. Lane,et al.  Hypothalamic malonyl-CoA as a mediator of feeding behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Gaetani,et al.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.

[26]  Roberto Conti,et al.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.

[27]  S. Chirala,et al.  Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Woods,et al.  C75 inhibits food intake by increasing CNS glucose metabolism , 2003, Nature Medicine.

[29]  C. Townsend,et al.  Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. , 2002, American journal of physiology. Endocrinology and metabolism.

[30]  D. Mangelsdorf,et al.  PPARα is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Macneil,et al.  Neither Agouti-Related Protein nor Neuropeptide Y Is Critically Required for the Regulation of Energy Homeostasis in Mice , 2002, Molecular and Cellular Biology.

[32]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Zhaohui Feng,et al.  Central administration of oleic acid inhibits glucose production and food intake. , 2002, Diabetes.

[34]  R. Rimondini,et al.  Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[35]  H. Fukuda,et al.  Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats. , 2001, European journal of biochemistry.

[36]  M. Permutt,et al.  Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia , 2001 .

[37]  C. Semenkovich,et al.  PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice. , 2001, The Journal of clinical investigation.

[38]  C. Bouchard.  Inhibition of food intake by inhibitors of fatty acid synthase. , 2000, The New England journal of medicine.

[39]  C. Townsend,et al.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.

[40]  M. Magnuson,et al.  Analysis of the Cre‐mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas , 2000, Genesis.

[41]  M. Fujimiya,et al.  Intracerebroventricularly administered corticotropin‐releasing factor inhibits food intake and produces anxiety‐like behaviour at very low doses in mice , 1999, Diabetes, obesity & metabolism.

[42]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[43]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[44]  L A Herzenberg,et al.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Semenkovich,et al.  Regulation of fatty acid synthase (FAS). , 1997, Progress in lipid research.

[46]  G. Pasternack,et al.  Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. , 1996, Cancer research.

[47]  M. Prentki,et al.  Evidence for an Anaplerotic/Malonyl-CoA Pathway in Pancreatic β-Cell Nutrient Signaling , 1996, Diabetes.

[48]  S. Dudek,et al.  Essential Amino Acids Regulate Fatty Acid Synthase Expression through an Uncharged Transfer RNA-dependent Mechanism* , 1995, The Journal of Biological Chemistry.

[49]  C. Semenkovich,et al.  Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA stability. , 1993, Journal of Biological Chemistry.

[50]  S. Woods,et al.  Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.

[51]  R. Ockner,et al.  Inhibition of rat liver acetyl coenzyme A carboxylase by long chain acyl coenzyme A and fatty acid. Modulation by fatty acid-binding protein. , 1977, The Journal of biological chemistry.

[52]  Joan,et al.  Inhibition of Rat Liver Acetyl Coenzyme A Carboxylase by Long Chain Acyl Coenzyme A and Fatty Acid , 2002 .

[53]  N. Wong,et al.  Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet. , 1992, Journal of lipid research.